» Articles » PMID: 11711691

Drug Interactions Update: Drugs, Herbs, and Oral Anticoagulation

Overview
Date 2001 Nov 17
PMID 11711691
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Management of warfarin drug interactions is often complicated by lack of information regarding interactions with new drugs and with herbal medicinals. The pharmaceutical industry has increased both the number and quality of drug interaction studies prior to marketing new agents. Interactions may still occur in patients, however, despite negative pre-marketing studies in healthy volunteers. The clinical significance and intensity of warfarin interactions with prescription drugs (e.g., celecoxib, proton pump inhibitors, and selective serotonin reuptake inhibitors) can often be predicted on the basis of known metabolic characteristics of the drugs and warfarin enantiomers. Drug interactions with herbal medicinals are much more difficult to characterize and predict because of the lack of federal regulations regarding safety, efficacy, and manufacturing standards. Published case reports of interactions between warfarin and even the most widely used herbal medicinals are limited. Practitioners are encouraged to report such interactions through the FDA MedWatch program.

Citing Articles

Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore.

Bernaitis N, Ching C, Teo S, Badrick T, Davey A, Crilly J J Clin Med. 2018; 7(5).

PMID: 29723987 PMC: 5977136. DOI: 10.3390/jcm7050097.


Gastroprotective efficacy and safety evaluation of scoparone derivatives on experimentally induced gastric lesions in rodents.

Son D, Lee G, Oh S, Lee S, Choi W Nutrients. 2015; 7(3):1945-64.

PMID: 25781220 PMC: 4377892. DOI: 10.3390/nu7031945.


Monitoring of anticoagulant therapy in heart disease: considerations for the current assays.

Boroumand M, Goodarzynejad H J Tehran Heart Cent. 2012; 5(2):57-68.

PMID: 23074569 PMC: 3466827.


Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital.

Gschwind L, Rollason V, Lovis C, Boehlen F, Bonnabry P, Dayer P Eur J Clin Pharmacol. 2012; 69(3):617-27.

PMID: 22903542 DOI: 10.1007/s00228-012-1358-7.


Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Ageno W, Gallus A, Wittkowsky A, Crowther M, Hylek E, Palareti G Chest. 2012; 141(2 Suppl):e44S-e88S.

PMID: 22315269 PMC: 3278051. DOI: 10.1378/chest.11-2292.


References
1.
Janetzky K, Morreale A . Probable interaction between warfarin and ginseng. Am J Health Syst Pharm. 1997; 54(6):692-3. DOI: 10.1093/ajhp/54.6.692. View

2.
Boullata J, Nace A . Safety issues with herbal medicine. Pharmacotherapy. 2000; 20(3):257-69. DOI: 10.1592/phco.20.4.257.34886. View

3.
Andersson T . Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet. 1996; 31(1):9-28. DOI: 10.2165/00003088-199631010-00002. View

4.
Marroum P, Uppoor R, Parmelee T, Ajayi F, Burnett A, Yuan R . In vivo drug-drug interaction studies--a survey of all new molecular entities approved from 1987 to 1997. Clin Pharmacol Ther. 2000; 68(3):280-5. DOI: 10.1067/mcp.2000.109366. View

5.
EISENBERG D, Davis R, Ettner S, Appel S, Wilkey S, Van Rompay M . Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998; 280(18):1569-75. DOI: 10.1001/jama.280.18.1569. View